Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

2017 Amyotrophic Lateral Sclerosis Pipeline Highlights Update - ResearchAndMarkets.com

Research and Markets
Posted on: 07 Mar 18

The "Amyotrophic Lateral Sclerosis Pipeline Highlights - 2017 Update" drug pipelines has been added to ResearchAndMarkets.com's offering.

Amyotrophic Lateral Sclerosis Pipeline Highlights - 2017 Update, provides most up-to-date information on key pipeline products in the global Amyotrophic Lateral Sclerosis market.

It covers emerging therapies for Amyotrophic Lateral Sclerosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Amyotrophic Lateral Sclerosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Amyotrophic Lateral Sclerosis pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Amyotrophic Lateral Sclerosis pipeline products by the company.

Short-term Launch Highlights:

Find out which Amyotrophic Lateral Sclerosis pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Amyotrophic Lateral Sclerosis Pipeline by Stages

2. Amyotrophic Lateral Sclerosis Pipeline by Drug Class

3. Amyotrophic Lateral Sclerosis Pipeline by Company

4. Amyotrophic Lateral Sclerosis Phase 3 Clinical Trial Insights

5. Amyotrophic Lateral Sclerosis Phase 2 Clinical Trial Insights

6. Amyotrophic Lateral Sclerosis Phase 1 Clinical Trial Insights

7. Amyotrophic Lateral Sclerosis Preclinical Research Insights

8. Amyotrophic Lateral Sclerosis Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/5s7q8n/2017_amyotrophic?w=4.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180307006374/en/

Business Wire
www.businesswire.com

Last updated on: 07/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.